Meilu Zhu

Title: Innovations in Prostate Cancer Diagnosis by Meilu Zhu

Introduction

Meilu Zhu is an innovative inventor based in Hong Kong, CN. He has made significant contributions to the field of medical imaging, particularly in the diagnosis of prostate cancer. His work focuses on enhancing the accuracy and efficiency of cancer detection through advanced imaging techniques.

Latest Patents

Meilu Zhu holds a patent for a "Task interaction network for prostate cancer diagnosis." This invention provides a task interaction network that can jointly perform segmentation and classification tasks based on multi-parametric magnetic resonance imaging scan images. The network comprises a backbone network, an auxiliary segmentation branch, a classification branch with a lesion awareness module, and a main segmentation branch featuring a category allocation module. The auxiliary segmentation branch predicts an initial lesion mask, which serves as location guidance for the classification branch. The lesion awareness module refines this mask for improved accuracy. Additionally, the classification branch's weights act as category prototypes, generating category guidance features to assist the main segmentation branch in performing the segmentation task.

Career Highlights

Meilu Zhu is affiliated with the City University of Hong Kong, where he continues to advance his research in medical imaging and cancer diagnosis. His innovative approach has garnered attention in the medical community, contributing to improved diagnostic methods.

Collaborations

Meilu Zhu collaborates with Yixuan Yuan, who is also involved in research related to medical imaging and cancer diagnosis. Their partnership enhances the development of innovative solutions in this critical field.

Conclusion

Meilu Zhu's contributions to prostate cancer diagnosis through his patented task interaction network exemplify the potential of innovation in medical technology. His work not only advances diagnostic accuracy but also paves the way for future research in cancer detection.